Uptravi 800-BEL (Selexipag Tablet) 800mcg

Uptravi 800-BEL (Selexipag) 800mcg tablets are prescribed for pulmonary arterial hypertension management. This medication helps improve exercise capacity and reduce symptoms. Store at room temperature and keep out of reach of children. Always follow healthcare provider instructions.

Strength

800mcg

Pack Size

60s

Storage

Ambient

Manufacturer / TM Owner

Actelion Pharmaceuticals

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Selexipag 800mcg tablets are primarily used to treat pulmonary arterial hypertension, a condition that causes high blood pressure in the lungs. It helps by relaxing blood vessels in the lungs, making it easier for the heart to pump blood. This medication is often prescribed when other treatments are not sufficient. It may also be used for other conditions as determined by a healthcare professional.

Side Effects

Common effects of Selexipag include headache, jaw pain, and flushing. Some users may experience nausea, diarrhea, or muscle pain. These effects are usually mild and temporary. If they persist or worsen, consult a healthcare provider. The medication works gradually to improve symptoms over time.

Precautions & Warnings

Store Selexipag 800mcg tablets at room temperature, away from moisture and heat. Keep the medication in its original packaging until ready to use. Avoid crushing or splitting tablets unless instructed by a healthcare provider. Inform your doctor about all medications and supplements you are taking before starting this treatment.

Avoid Interactions

Selexipag may interact with strong CYP2C8 inhibitors, such as gemfibrozil, increasing its effects. Alcohol and grapefruit juice may also affect how this medication works. Always discuss potential interactions with your healthcare provider. Certain herbal supplements, like St. John’s wort, may reduce its effectiveness.

Frequently Asked Questions

Selexipag 800mcg is used to treat pulmonary arterial hypertension by relaxing blood vessels in the lungs.

Store Selexipag 800mcg tablets at room temperature, away from moisture and heat.

Consult your healthcare provider before combining Selexipag with other medications or supplements.

Common side effects include headache, jaw pain, and flushing.

No, Selexipag 800mcg requires a prescription from a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.